Back

Anti-hypertensive agents: is there a benefit beyond lowering blood pressure?

12 April 2026 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: Pharmacological treatment for atrial fibrillation Arrhythmias, General EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Michiel Rienstra

University Medical Centre Groningen, Groningen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors: a new era in atrial fibrillation prevention?
Professor D. Linz (Maastricht, NL)
Slides
Presentation thumbnail
Antifibrotic drugs: the journey to prime time
Doctor S. Matsumoto (Tokyo, JP)
Slides
Presentation thumbnail
The emerging promise of GLP-1 receptor agonists
Professor V. Caso (Perugia, IT)
Slides

Access the full session

Session thumbnail
Pharmacological treatment for atrial fibrillation

The Event

Event poster

EHRA 2026

12 April 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
The relationship between blood pressure and mortality in the general population - it is not as simple as one might think - results from 20 years follow-up in the Study of Health in Pomerania
25 April 2024
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
1 September 2025
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Congress Presentation
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources